Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Fallara

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
Current Opinion in Urology|March 20, 2021
How to improve outcome in nephron-sparing surgery: the impact of new techniquesDaniele Cignoli, Giuseppe Fallara, Alessandro Larcher, et al.
Plos One|December 28, 2020
Observational study on time on treatment with abiraterone and enzalutamideGiuseppe Fallara, Ingela Franck Lissbrant, Johan Styrke, et al.
International Journal of Impotence Research|October 1, 2020
Erectile function after focal therapy for localized prostate cancer: a systematic reviewGiuseppe Fallara, Paolo Capogrosso, Paolo Maggio, et al.
Acta Oncologica (Stockholm, Sweden)|March 20, 2024
Time trends in the use of curative treatment in men 70 years and older with nonmetastatic prostate cancerFrida Lundberg, David Robinson, Ola Bratt, et al.
Acta Oncologica (Stockholm, Sweden)|December 11, 2020
Rapid ascertainment of uptake of a new indication for abiraterone by use of three nationwide health care registries in SwedenGiuseppe Fallara, Ingela Franck Lissbrant, Johan Styrke, et al.
Acta Oncologica (Stockholm, Sweden)|September 17, 2021
Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of SwedenGiuseppe Fallara, Charlotte Alverbratt, Hans Garmo, et al.
The Journal of Sexual Medicine|June 26, 2022
Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous TestosteroneGiuseppe Fallara, Edoardo Pozzi, Federico Belladelli, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|April 28, 2022
Morbidity and mortality in men: Role of androgensGiuseppe Fallara, Edoardo Pozzi, Christian Corsini, et al.
Acta Oncologica (Stockholm, Sweden)|January 4, 2022
Time on treatment with abiraterone in men with <i>de novo</i> metastatic castration sensitive prostate cancer: a drug utilization studyRolf Gedeborg, Hans Garmo, Camilla Thellenberg-Karlsson, et al.
The World Journal of Men'S Health|January 2, 2024
Impact of Hydroxyurea to Treat Haematological Disorders on Male Fertility: Two Case Reports and a Systematic ReviewSimone Cilio, Giuseppe Fallara, Maria Teresa Lupo Stanghellini, et al.
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Current Opinion in Urology|March 20, 2021
How to improve outcome in nephron-sparing surgery: the impact of new techniquesDaniele Cignoli, Giuseppe Fallara, Alessandro Larcher, et al.
Plos One|December 28, 2020
Observational study on time on treatment with abiraterone and enzalutamideGiuseppe Fallara, Ingela Franck Lissbrant, Johan Styrke, et al.
International Journal of Impotence Research|October 1, 2020
Erectile function after focal therapy for localized prostate cancer: a systematic reviewGiuseppe Fallara, Paolo Capogrosso, Paolo Maggio, et al.
Acta Oncologica (Stockholm, Sweden)|March 20, 2024
Time trends in the use of curative treatment in men 70 years and older with nonmetastatic prostate cancerFrida Lundberg, David Robinson, Ola Bratt, et al.
Acta Oncologica (Stockholm, Sweden)|December 11, 2020
Rapid ascertainment of uptake of a new indication for abiraterone by use of three nationwide health care registries in SwedenGiuseppe Fallara, Ingela Franck Lissbrant, Johan Styrke, et al.
Acta Oncologica (Stockholm, Sweden)|September 17, 2021
Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of SwedenGiuseppe Fallara, Charlotte Alverbratt, Hans Garmo, et al.
The Journal of Sexual Medicine|June 26, 2022
Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous TestosteroneGiuseppe Fallara, Edoardo Pozzi, Federico Belladelli, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|April 28, 2022
Morbidity and mortality in men: Role of androgensGiuseppe Fallara, Edoardo Pozzi, Christian Corsini, et al.
Acta Oncologica (Stockholm, Sweden)|January 4, 2022
Time on treatment with abiraterone in men with <i>de novo</i> metastatic castration sensitive prostate cancer: a drug utilization studyRolf Gedeborg, Hans Garmo, Camilla Thellenberg-Karlsson, et al.
The World Journal of Men'S Health|January 2, 2024
Impact of Hydroxyurea to Treat Haematological Disorders on Male Fertility: Two Case Reports and a Systematic ReviewSimone Cilio, Giuseppe Fallara, Maria Teresa Lupo Stanghellini, et al.
Pageof 15